1-15 of 461
Subcutaneous Lp(a)-Lowering Therapies: Understanding the Evidence
Heart MattersSubcutaneous Lp(a)-Lowering Therapies: Understanding the Evidence
M. Melih Dogan, MD
Updated AACE Guidance on Managing Dyslipidemia in T2D
Heart MattersUpdated AACE Guidance on Managing Dyslipidemia in T2D
Scott D. Isaacs, MD FACP, FACE
Exploring the Risk of Type 2 Diabetes Following SARS-CoV-2 Infection
Clinician's RoundtableExploring the Risk of Type 2 Diabetes Following SARS-CoV-2 Infection
Carolyn Bramante
Key CKD Updates from the 2026 NKF Meetings
Clinician's RoundtableKey CKD Updates from the 2026 NKF Meetings
Charles Turck, PharmD, BCPS, BCCCP
Matthew R. Weir, MD
Suneel Udani, MD
Contraceptive Counseling in the Era of GLP-1 Therapies
Advances in Women's HealthContraceptive Counseling in the Era of GLP-1 Therapies
Shelina Ramnarine, PhD
Halina Yee, MD
Extended Dosing Strategies for Diabetic Retinopathy and DME
Eye on Ocular HealthExtended Dosing Strategies for Diabetic Retinopathy and DME
Michael A. Klufas, MD
- advertisement
ILLUMIN-8: Real-World Outcomes with Aflibercept 8 Mg in DME
Eye on Ocular HealthILLUMIN-8: Real-World Outcomes with Aflibercept 8 Mg in DME
Michael A. Klufas, MD
Optimizing Anti-VEGF Selection in Diabetic Macular Edema
Eye on Ocular HealthOptimizing Anti-VEGF Selection in Diabetic Macular Edema
Michael A. Klufas, MD
Not Just for Diabetes: Broadening uACR Screening to CV Risk Populations
Conversations in CV Risk AssessmentNot Just for Diabetes: Broadening uACR Screening to CV Risk Populations
Brian P. McDonough, MD, FAAFP
Anu Lala, MD
Survodutide in Obesity: Insights from SYNCHRONIZE-1
Diabetes DiscourseSurvodutide in Obesity: Insights from SYNCHRONIZE-1
Carel le Roux, MBChB, MSC, FRCP, FRCPath, PhD
Addressing Cost-Related Medication Non-Adherence in Diabetes
Diabetes DiscourseAddressing Cost-Related Medication Non-Adherence in Diabetes
Kimberly Narain, MD, MPH, PhD
Understanding Residual Cardiovascular Risk in CKD and T2D
Diabetes DiscourseUnderstanding Residual Cardiovascular Risk in CKD and T2D
John W. Ostrominski, MD, MPH
- advertisement
Digital Innovation in Diabetes Prevention for Older Adults
Diabetes DiscourseDigital Innovation in Diabetes Prevention for Older Adults
Steve Jackson, PharmD
Souptik Barua, PhD
Emily Johnston, MPH, PhD
Is It Familial or Multifactorial Chylomicronemia Syndrome?
On the Frontlines of Familial Chylomicronemia SyndromeIs It Familial or Multifactorial Chylomicronemia Syndrome?
Steve Jackson, PharmD
Michael D. Shapiro
Incretin-Based Advances in Obesity and T2D Care
Diabetes DiscourseIncretin-Based Advances in Obesity and T2D Care
Javier Morales, MD, FACP, FACE
